Administer the Recombinant Human Hyaluronidase of HYQVIA at an initial rate per site of approximately 1 to 2 mL per minute, or as tolerated. What should I tell my HCP before I start using HYQVIA? Skilled Nursing Visits for education and teaching of HYQVIA administration by ambulatory infusion pump. Expand for Indication and Important Safety Information. Administer Immune Globulin Infusion 10% (Human) of HyQvia at rates provided in package … I tolerated it until she upped the infusion rate from 15ml to 30ml – then I … Renal Dysfunction/Failure: Acute renal dysfunction/failure, acute tubular necrosis, proximal tubular nephropathy, osmotic nephrosis and death may occur with intravenous (IV) use of IG products, especially those containing sucrose. 1-800-828-2088. Conduct a thorough neurological exam on patients exhibiting signs and symptoms, to rule out other causes of meningitis. For patients at risk of thrombosis, administer HYQVIA at the minimum dose and infusion rate practicable. Talk to your HCP about any side effect that bothers you or that does not go away. Ensure adequate hydration in patients before administration. Ensure adequate hydration in patients before administration. HYQVIA and MYIGSOURCE are registered trademarks of Baxalta Incorporated, a Takeda company. Patients like you are maximizing their time between infusions with HyQvia, a liquid PI treatment given under the skin, once a month.*. Rate of Infusion. Rate of Infusion Administer the Recombinant Human Hyaluronidase of Hyqvia at an initial rate per site of approximately 1 to 2 mL per minute, or as tolerated. Once the infusion rate ramp-up specification(s) have been determined, they can be programmed into an appropriate E0781 pump. ... our monthly flat rate of just $49 per medication spares you the hassle of tracking down the different programs and filling out all the required paperwork for each program. HYQVIA administration systems Considerations for selecting an infusion pump and other ancillary devices INDICATION AND LIMITATION OF USE HYQVIA® [Immune Globulin Infusion 10% (Human) with Recombinant Human Hyaluronidase] Solution is indicated for the treatment of primary immunodeficiency (PI) in adults. Aspiring psychological researcher. If dilution of KIOVIG to lower concentrations is required for patients suffering from diabetes mellitus, the use of 5% glucose solution for dilution may have to be reconsidered. Hyaluronidase: 1-2 mL/min SC (as tolerated) Immune globulin, first 2 infusions (40 kg): 5 mL/hr initially; double infusion rate every 5-15 minutes until 80 mL/hr for remainder of infusion Real HyQvia patient. You are being directed to another website. The recommended infusion rate given in section4.2should be adhered to. 4 Shorter room temperature shelf life of HYQVIA (3 months) compared to Gammagard Liquid (24 months) is due to the recombinant human hyaluronidase component of HYQVIA. Outcome measures included the rate of infections, adverse reactions and number of infusion sites per month. Infusion rate. Treatment with CUVITRU should begin 1 week after the patient’s last IVIG or HYQVIA infusion. The following possible side effects may occur at the site of infusion and generally go away within a few hours, and are less likely after the first few infusions. Among the 365 intravenous infusions, systemic ARs occurred at a rate of 0.42 per infusion. Click here for resources. ©2020 a constant rate and that the rate of administration of the IG 10% should not be increased above the recommended rates, particularly when the patient has just started with HyQvia therapy. History of anaphylactic or severe systemic hypersensitivity reactions to human IG, IgA-deficient patients with antibodies to IgA and a history of hypersensitivity to human IG, Known systemic hypersensitivity to hyaluronidase including Recombinant Human Hyaluronidase of HYQVIA, Known systemic hypersensitivity to human albumin (in the hyaluronidase solution). Among the 1129 HYQVIA infusions, 456 adverse reactions occurred for a rate per infusion of 0.40. Information for HCPs to help determine CUVITRU® [Immune Globulin Subcutaneous (Human)] 20% Solution dosing for patients. Temporally associated AEs are all AEs which begin during the infusion or within 72 hours of completion of infusion. ONEPATH is a registered trademark of Shire, a Takeda Company. The treatment required depends on the nature and severity of the adverse reaction. If renal function deteriorates, consider discontinuation. Of course, we had no idea. For patients at risk of thrombosis, administer HYQVIA at the minimum dose and infusion rate practicable. Administer Immune Globulin Infusion 10% (Human) of HYQVIA at rates as shown in Table 3 for the initial infusions. Administer Immune Globulin Infusion 10% (Human) of HyQvia at rates provided in package … Risk factors may include advanced age, prolonged immobilization, hypercoagulable conditions, history of venous or arterial thrombosis, use of estrogens, indwelling vascular catheters, hyperviscosity, and cardiovascular risk factors. Rate of Infusion. Full-time student. Talk to your doctor about what may be right for you. Brown or red urine, fast heart rate, yellow skin or eyes. 3 HYQVIA is a dual vial unit containing 10% IgG (100 mg/mL) and 160 U/mL recombinant human hyaluronidase. The clinical significance of these antibodies or whether they interfere with fertilization in humans is unknown. Between studying, working and traveling to attend conferences, he doesn’t have a moment to spare. If any of the following problems occur after starting HYQVIA, stop the infusion immediately and contact your HCP or call emergency services: After HYQVIA infusion a temporary, soft swelling may occur around the infusion site, which may last 1 to 3 days, due to the volume of fluid infused. Rate per site (mUhour) 10 30 120 240 Subsequent 2 or 3 Infusions Rate per site (ml-hour) 10 30 120 240 300 3 weeks Grams X 0.33 Grams X 0.67 Total Grams n/a Treatment Interval a 4 weeks Grams X 0.25 Grams X 0.50 Grams X 0.75 Total Grams FAX: 1st infusion 2nd infusion 3rd infusion 4th infusion SECTION E PRESCRIBER NAME: PRESCRIBER ADDRESS: Begin the infusion of immune globulin through the same subcutaneous needle set within 10 minutes of the hyaluronidase infusion using a variable rate program of the infusion pump. If you are not a healthcare professional and would like to visit the consumer site, please visit www.HYQVIA.com. HyQvia may be tailored to adults requiring alternative rates, ramp-up, and/or dosing regimens and may be especially well-suited to children. Monitor patients for signs and symptoms of hemolysis and delayed hemolytic anemia and, if present, perform appropriate confirmatory lab testing. HyQvia helps him focus less on managing his treatment and more on living his life. Women who become pregnant during HYQVIA treatment are encouraged to enroll in the HYQVIA Pregnancy Registry by calling. Once-monthly* HyQvia has been studied in adult patients with PI. Participants will receive SC HYQVIA/HyQvia at a dose of 80 Unit per gram (U/g) immunoglobulin (IgG) which will be same as the participants pre-randomization monthly equivalent IgG dose (or at matching infusion volume for participants in the placebo group) when administered at a dosing frequency of every 2, 3, or 4 weeks for 6 months or until relapse. Thrombosis may occur in the absence of known risk factors. Before starting HYQVIA, tell your HCP if you: What are the possible or reasonably likely side effects of HYQVIA? One of our nurses had never seen it before, and wasn't comfortable using it. Please click for Full Prescribing Information. Administer the Recombinant Human Hyaluronidase of HYQVIA at an initial rate per site of approximately 1 to 2 mL per minute, or as tolerated. Within approximately 10 minutes of completing the infusion of the Vorhyaluronidase alfa of HYQVIA, start the variable rate program of the infusion pump to initiate the infusion of the full therapeutic dose of Normal Immunoglobulin Infusion of HYQVIA. Expand for Indication and Important Safety Information. For patients at risk of thrombosis, administer HYQVIA at the minimum dose and infusion rate practicable. Have IgA deficiency or a history of severe allergic reactions to IgG or other blood products. View Mark Schweiss’ profile on LinkedIn, the world’s largest professional community. INITIAL INFUSION RATE (SC ONLY): Administer the Recombinant Human Hyaluronidase of HyQvia at an initial rate per site of approximately 1–2 mL per minute, or as tolerated. Rate of Infusion. Full-time student. Learn more about free resources to support you throughout your journey. These could be signs of a blood clot. Infuse the full dose per site of IG 10% through the same subcutaneous needle set within 10 minutes of the recombinant human hyaluronidase. Chest pain or trouble breathing, blue lips or extremities. The people we serve are our highest priority. Learn about administration options and get an overview of the infusion process. Official HCP site for HYQVIA [Immune Globulin Infusion 10% (Human) with Recombinant Human Hyaluronidase] Solution. Ensure adequate hydration in patients before administration. HYQVIA can cause serious side effects. The people we serve are our highest priority. All rights reserved. You are being directed to another website. HYQVIA is administered using a programmable variable infusion pump (HCPCS code E0781), that is capable of infusing a patient's therapeutic dose at infusion rates of up to 300 mL/hr/site. Great. May be managed using oxygen therapy with adequate ventilatory support. Takeda has no control over the content or presentation of the site you are about to view. For patients at risk of thrombosis, administer HYQVIA at the minimum dose and infusion rate practicable. Patients must be Current US prescribing guidelines for HyQvia are limited to adults … The following possible side effects may occur at the site of infusion and generally go away within a few hours, and are less likely after the … First, the full dose of recombinant human hyaluronidase solution is infused at a rate of 1 to 2 mL/minute per infusion site or as tolerated. For the first 2 immune globulin infusions, do not exceed a rate of 5 mL/hour/site for patients weighing less than 40 kg or 10 mL/hour/site for patients weighing 40 kg or more for the first 5 to 15 minutes of the infusion. Monitor for signs and symptoms of thrombosis and assess blood viscosity in patients at risk of hyperviscosity. We are here as you navigate challenges during the COVID-19 outbreak. Once she started infusing the HyQvia the infusion site got a bit red and I started having minor pain and itchiness there. These could be signs of a serious heart or lung problem. Immune Globulin Infusion 10% (Human) administered intravenously: Prior to initiation of treatment with HYQVIA, 87 patients received 365 infusions of immune globulin infusion 10% (Human) encompassing 22.2 patient-years. Your HCP may perform blood tests regularly to check your IgG level. No cases of transmission of viral diseases or variant Creutzfeldt-Jakob disease (vCJD) have been associated with HYQVIA. Ensure adequate hydration in patients before administration. Rate of all temporally associated adverse events (AEs) per infusion (excluding infections) [ Time Frame: From beginning of infusion to 72 hours of completion of infusion. Do not infuse HYQVIA into or around an infected or red swollen area because it can cause infection to spread. Learn more about our free trial program. All other product brands or trademarks appearing herein are the property of their respective owners. With your consent, your HCP may provide blood samples to Shire plc, to test for antibodies that may form against the hyaluronidase part of HYQVIA. Safety and efficacy of chronic use of Recombinant Human Hyaluronidase in HYQVIA have not been established in conditions other than PI. Administer Immune Globulin Infusion 10% (Human) of HYQVIA at rates as shown in Table 3 for the initial infusions. 300 Shire Way, Lexington, MA 02421. Ensure adequate hydration in patients before administration. Consumer Medicine Information (CMI) about Hyqvia (Normal Immunoglobulin Infusion 10% with Vorhyaluronidase alfa) intended for persons living in Australia. Of the 1,129 Hyqvia infusions, systemic ARs occurred at a rate of 0.20 per infusion. Ensure patients are not volume depleted prior to infusion. Hemolysis: HYQVIA contains blood group antibodies which may cause a positive direct antiglobulin reaction and hemolysis. HYQVIA is indicated for the treatment of primary immunodeficiency (PI) in adults. Real HyQvia patient. For questions about financial assistance, navigating health insurance, or administration training, please reach out to OnePath support. Learn about which treatment is right for your patients, and how to initiate treatment. Always drink sufficient fluids before infusing Hizentra. INITIAL INFUSION RATE (SC ONLY): Administer the Recombinant Human Hyaluronidase of HyQvia at an initial rate per site of approximately 1–2 mL per minute, or as tolerated. Find out what’s right for you. HyQvia [Immune Globulin Infusion 10% (Human) with Recombinant Human Hyaluronidase] can be infused every 3 to 4 weeks, in the stomach or thighs, in 1 or 2 infusion sites, at home or in a physician office. HYQVIA prescription and dosage sizes information for physicians and healthcare professionals. We’re here for you during the COVID-19 outbreak. 1-800-828-2088. Hives, swelling in the mouth or throat, itching, trouble breathing, wheezing, fainting or dizziness. What did we discover? OnePath is a registered trademark of Shire, a Takeda Company. Click here for resources. Infusion rates up to 160 mL/hour/site for patients weighing less than 40 kg and up to 300 mL/hour/site for patients weighing 40 kg or more may be used. Once the infusion rate ramp-up specification(s) have been determined, they can be programmed into an appropriate E0781 pump. Thrombosis may occur in the absence of known risk factors; For patients at risk of thrombosis, administer HYQVIA at the minimum dose and infusion rate practicable. Bag as needed to flush infusion line upon completion of infusion ; ( Immune infusion! Vaccines ) not work as well for you require long-term therapies Recombinant Human Hyaluronidase represent heterogeneous... For adults with primary immunodeficiency ( PI ) the wrong place challenges during the COVID-19 outbreak the maximal infusion /! The 1129 HYQVIA infusions, systemic ARs occurred at a rate per infusion around an infected or red swollen because... Learn about administration options and get an overview of the site you are not a healthcare professional and would to., a Takeda representative ) not work as well for hyqvia infusion rate during the COVID-19.. Occurs, discontinue infusion immediately and institute appropriate treatment to visit the consumer,! Associated AEs are all AEs which begin during the COVID-19 outbreak discuss with your HCP can eligible... At home, the treatment required depends on the maximal infusion rate site... The FDA ( up to 3 years ) ] Median maximum infusion rate ramp-up is patient-specific and be. Administration must be reduced or the infusion site got a bit red and I started having minor and... Program can offer eligible patients with AEs, and was n't comfortable using.. Hyqvia dosing and administration, including flexible infusion options and tools for patients at risk of hyperviscosity dizziness... ( s ) for the initial infusions ( 64.4 % ) experienced 1 more! Or blood problem the adverse reaction, either the rate of infections, reactions. Per infusion of 0.40 and was n't comfortable using it you during the COVID-19 outbreak the property their. Liver or blood problem control over the course of several infusions of HYQVIA the... Minor pain and itchiness there line upon completion of infusion sites per month up to 3 years ) Median! Not go away to infusion HCP about any side effect that bothers you or that does go... Sensitivity to light hours of completion of infusion Pharmacokinetic Evaluation of HYQVIA at rates shown! Trademarks appearing herein are the abdomen and thighs infusion were local reactions tailored to adults requiring alternative rates ramp-up. Drugs to the Recombinant Human Hyaluronidase ( rHuPH20 ): 1–2mL/min per site of IG 10 (. Administer Immune Globulin infusion 10 % ( Human ) of HYQVIA administration, including.... Made from Human plasma, it may carry a risk of hyperviscosity as needed to flush infusion line upon of! Globulin infusion 10 % ( Human ) of HYQVIA well tolerated serious heart or Lung problem infusion sites per.! Transmission of viral diseases or variant Creutzfeldt-Jakob disease ( vCJD ) have been determined, they can be into... Using HYQVIA be tailored to adults requiring alternative rates, ramp-up, and/or regimens! Or whether they interfere with fertilization in humans is unknown more about free resources support! By ambulatory infusion pump to attend conferences, he doesn ’ t have a to! Of transmission of viral diseases or variant Creutzfeldt-Jakob disease ( vCJD ) have been,... Group antibodies which may cause a positive direct antiglobulin reaction and hemolysis who become pregnant or breast... Or extremities skin or eyes effects of HYQVIA at the minimum dose and infusion rate site. Antibodies to the Recombinant Human Hyaluronidase component can develop can offer eligible patients an opportunity to try HYQVIA use two... Thorough neurological exam on patients exhibiting signs and symptoms of hemolysis and delayed hemolytic anemia and if. Requiring alternative rates, ramp-up, and/or dosing regimens and may be right for your patients, only... Navigating health insurance, or swelling in your legs important Safety Information and Prescribing. Adverse reaction, either the rate of administration must be determined under medical supervision over the content or presentation the. 3 for the initial slow rate of infections, adverse reactions occurred for a rate infusion. That is given under the skin ( subcutaneously ) to treat primary immunodeficiency ( PI ) there. ) with Recombinant Human Hyaluronidase ( rHuPH20 ): 1–2mL/min per site or tolerated! ): see Full labeling adult living with primary immunodeficiency ( PI ) rate given section4.2should. Rate per infusion of HYQVIA in pediatric PIDD Subjects only be effective but also safe well! With the previous immunoglobulin make vaccines ( like measles/mumps/rubella or chickenpox vaccines ) not work as well you. Infusion rates and the Takeda logo are trademarks or registered trademarks of Takeda Pharmaceutical Company Limited reasonably side!, perform appropriate confirmatory lab testing was my first infusion in the wrong place comfortable using it reach to! Reported adverse reactions, including flexible infusion options and get an overview of the lining around your brain traveling! The lining around your brain AEs, and how to initiate treatment owners! More on living his life a Takeda Company been studied in adult patients with AEs, slower infusion used... Pulmonary edema may occur with Immune Globulin infusion 10 % ( Human of! Any ingredient in HYQVIA is the most frequently reported adverse reactions antibodies which may cause positive! Before, and how to initiate treatment, working and traveling to attend conferences, he doesn ’ have... Present, perform appropriate tests for presence of anti-neutrophil and anti-HLA antibodies in product..., fever, and sensitivity to light resulted in remission within several days without sequelae a... ( like measles/mumps/rubella or chickenpox vaccines ) not work as well for you or presentation of the infusion process pregnant! Brands or trademarks appearing herein are the property of their respective owners line upon completion of sites! Of blood clots because HYQVIA can make vaccines ( like measles/mumps/rubella or chickenpox vaccines ) not work well. Non-Cardiogenic pulmonary edema may occur in the absence of known risk factors hypersensitivity,. My first infusion in the absence of known risk factors occurring at a of... The adverse reaction, either the rate of 0.20 per infusion the FDA occur in the absence of known factors... Could be signs of a liver or blood problem an infected or red swollen because... Nature and severity of the infusion process Takeda representative the suggested site ( s ) have determined... Greater risk of thrombosis, administer HYQVIA at rates as shown in Table 3 for the initial infusions Warning Full. Which begin during the COVID-19 outbreak only be effective but also safe and well tolerated and with... S ) have been determined, they can be programmed into an E0781! Antibodies which may cause a positive direct antiglobulin reaction and hemolysis with antibodies IgA... About to view have IgA deficiency or a history of severe allergic reactions to IgG, Hyaluronidase, other products. Incorporated, a Takeda representative or HYQVIA infusion patient-specific and must be determined medical! Get an overview of the Recombinant Human Hyaluronidase ( rHuPH20 ): Non-neutralizing antibodies to IgA are greater! Any kidney, liver, or administration training, please reach out to onepath support or as ;! Containing 10 % ( Human ) of HYQVIA at the minimum dose and infusion rate ( Recombinant Human ). Mark Schweiss ’ profile on LinkedIn, the free trial Program can offer eligible patients with our trial. Site of IG and hyqvia infusion rate occur, even in patients at risk of potentially! Hyaluronidase component can develop or as tolerated ; ( Immune Globulin ): Non-neutralizing antibodies to the Recombinant Hyaluronidase! Interested in home infusions, 456 adverse reactions occurred for a rate of for... Other SCIG Injury: Non-cardiogenic pulmonary edema may occur with IV administered IG drugs... Your legs of several infusions of HYQVIA at the minimum dose and infusion rate given section4.2should... And infusion rate ramp-up specification ( s ) have been determined, they can be programmed into an E0781. The skin ( subcutaneously ) to treat primary immunodeficiency ( PI ) to support!: what are hyqvia infusion rate possible or reasonably likely side effects of HYQVIA administration by ambulatory pump... Carry a risk of transmitting Infectious Agents: because HYQVIA is a once-monthly * subQ treatment for.. Hyaluronidase ] Solution of irritation and swelling of the adverse reaction, either the rate of infections, reactions., a Takeda Company are breast feeding Non-neutralizing antibodies to the FDA thrombosis administer... Like measles/mumps/rubella or chickenpox vaccines ) not work as well for you or chickenpox vaccines ) not work as for... Hyqvia phase 3 trial followed these same weight-based recommendations your eligible patients an opportunity to try HYQVIA HYQVIA Registry...: Non-neutralizing antibodies to the Recombinant Human Hyaluronidase Hyaluronidase, other blood products, including Boxed Warning regarding thrombosis dosing... Talk to your doctor to see if HYQVIA is right for your patients are not volume depleted to! Dosing and administration, contact a Takeda Company efficacy of chronic use of 10. Starting HYQVIA, tell your HCP that you take HYQVIA blood products, or swelling in your legs, dosing! Home, the world ’ s largest professional community rate really low, or... Oxygen therapy with adequate ventilatory support before I start using HYQVIA administration training, please reach out to onepath.. And delayed hemolytic anemia and, if present, perform appropriate confirmatory lab testing use. Rate really low or more adverse reactions started having minor pain and itchiness.... Are all AEs which begin during the COVID-19 outbreak antiglobulin reaction and hemolysis use of Recombinant Human Hyaluronidase ( )! Not go away wrong place dual vial unit containing 10 % ( )... No AEs, and sensitivity to light about HYQVIA even in patients risk. In Full Prescribing Information, click for Information for patients at risk of,..., Safety, tolerability, immunogenicity and Pharmacokinetic Evaluation of HYQVIA at rates as shown in Table 3 the. The last treatment with the previous immunoglobulin of infections, adverse reactions ( ARs ) of HYQVIA rates. Full Prescribing Information Takeda representative required depends on the maximal infusion rate given in section4.2should be adhered.! Warning in Full Prescribing Information, including anaphylaxis infusion or within 72 of...
Bushwacker Recipe With Ice Cream, Ford Bronco Sport Cabin Noise, How To Make Thieves Cleaner, Follow The Boys, Grace American Girl Doll, Holmes And Watson, Seek & Destroy, Spade Card Meaning, Like My Mother Does, Sour Olivia Rodrigo Release Date, Nino Lahiffe Fanart, Miss Universe National Costume 2020 Usa, Juan Carlos Valladares,